Human-centered AI - A dual-layer model for clinical research excellence
At DIA Global 2026, Aneiss Ghodsi shared actionable insights for implementing a dual-layer AI strategy that combines enterprise automation with citizen-developer innovation. This approach helps reduce manual workloads, accelerate clinical operations, and maintain regulatory compliance, while reinforcing rather than replacing human expertise.
Related Insights
Blog
Regulatory submissions as a source of insight: How AI can amplify the value of our work
Jul 15, 2026
CTB Blog
Modeling & simulation and artificial intelligence for early drug development
Jul 14, 2026
Blog
The connected submission - How AI, automation, and intelligence are changing the regulatory ecosystem
Jul 1, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Podcast
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention
Jan 6, 2025
Whitepaper
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
Nov 25, 2024
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Transforming evidence generation: How predictive AI can optimize clinical development
Sep 3, 2024
Blog
The future of drug development: Leveraging EMA support for use of alternative nonclinical approaches
Jun 6, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Article
Parexel principles for artificial intelligence (AI)
Mar 6, 2024
Related Insights
Blog
Regulatory submissions as a source of insight: How AI can amplify the value of our work
Jul 15, 2026
CTB Blog
Modeling & simulation and artificial intelligence for early drug development
Jul 14, 2026
Blog
The connected submission - How AI, automation, and intelligence are changing the regulatory ecosystem
Jul 1, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Podcast
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention
Jan 6, 2025
Whitepaper
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
Nov 25, 2024
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Transforming evidence generation: How predictive AI can optimize clinical development
Sep 3, 2024
Blog
The future of drug development: Leveraging EMA support for use of alternative nonclinical approaches
Jun 6, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Article
Parexel principles for artificial intelligence (AI)
Mar 6, 2024